| IT |
Report |
Adjusted EPS |
BEAT |
pred ~$3.90 vs. cons ~$3.77 |
HIGH |
| IT |
Report |
TotalEnterprise Contract Value FX-neutral % |
BEAT |
pred ~+2.5% vs. cons/prior-qtr ~+1% |
MEDIUM |
| IT |
Report |
Total revenue |
IN-LINE |
pred ~$1.71B vs. cons ~$1.70B |
MEDIUM |
| IT |
Guide |
FY26 Adjusted EPS guide (raise) |
BETTER |
guide ~$13.65 vs. cons ~$13.61 (FY26) |
MEDIUM |
| IT |
Guide |
FY26 Adjusted EBITDA guide (raise) |
BETTER |
guide ~$1.56B vs. cons ~$1.545B (FY26) |
MEDIUM |
| IT |
Guide |
FY26 revenue guide (raise) |
BETTER |
guide ~$6.44B vs. cons ~$6.42B (FY26) |
LOW |
| IT |
Guide |
Ex-Fed CV growth trajectory (key commentary) |
UNKNOWN |
pred ~+3.5-4% vs. Q1 ~+3.5% (2H26 exit) |
LOW |
| IT |
Guide |
GTS/GBS wallet (net dollar) retention |
UNCHANGED |
pred GTS ~97%/GBS ~98% vs. Q1 97%/98% |
LOW |
| IT |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.5% |
— |
LOW |
| IT |
Return |
5-day cumulative residual |
+1.0% (FADE) |
Highly bimodal print into a ~30% pre-earnings bounce that already faded ~8% off the Jul-29 peak. Base case: near-certain EPS beat + a buyback-driven FY26 guide raise + mechanically easing U.S. federal drag lifts total CV growth off +1%, driving a modest relief pop. But the raise is cost/repurchase-led rather than organic (revenue growth still ~1%), and the acceleration in the ex-Fed core plus retention is likely only steady, not the crisp step-up bulls need. As the out-period math shows the top-line/CV trajectory is still low-single-digit and the AI-disintermediation overhang unresolved, initial gains fade over the week; two prior prints (~-28%, ~-20%) keep buyers cautious and cap follow-through. |
LOW |